ALMD Stock Overview
Allmed Solutions Ltd engages in the development, manufacture, and marketing of minimally invasive products in various medical disciplines in Israel and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Allmed Solutions Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪0.41 |
52 Week High | ₪0.47 |
52 Week Low | ₪0.28 |
Beta | 0.64 |
1 Month Change | 0.97% |
3 Month Change | 8.92% |
1 Year Change | 50.91% |
3 Year Change | -31.52% |
5 Year Change | -32.85% |
Change since IPO | -97.87% |
Recent News & Updates
Shareholder Returns
ALMD | IL Medical Equipment | IL Market | |
---|---|---|---|
7D | -4.2% | -1.5% | 0.3% |
1Y | 50.9% | 4.8% | 11.6% |
Return vs Industry: ALMD exceeded the IL Medical Equipment industry which returned 4% over the past year.
Return vs Market: ALMD exceeded the IL Market which returned 9.8% over the past year.
Price Volatility
ALMD volatility | |
---|---|
ALMD Average Weekly Movement | 4.7% |
Medical Equipment Industry Average Movement | 5.4% |
Market Average Movement | 4.4% |
10% most volatile stocks in IL Market | 8.4% |
10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: ALMD has not had significant price volatility in the past 3 months.
Volatility Over Time: ALMD's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 19 | Shay Arotchas | www.almd-solutions.com |
Allmed Solutions Ltd engages in the development, manufacture, and marketing of minimally invasive products in various medical disciplines in Israel and internationally. The company offers medical devices for the treatment of type 2 diabetes in obese and overweight patients; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It is also involved in the development of mitral valve regurgitation solution.
Allmed Solutions Ltd Fundamentals Summary
ALMD fundamental statistics | |
---|---|
Market cap | ₪40.40m |
Earnings (TTM) | ₪1.42m |
Revenue (TTM) | n/a |
28.4x
P/E Ratio0.0x
P/S RatioIs ALMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALMD income statement (TTM) | |
---|---|
Revenue | ₪0 |
Cost of Revenue | ₪0 |
Gross Profit | ₪0 |
Other Expenses | -₪1.42m |
Earnings | ₪1.42m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.015 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did ALMD perform over the long term?
See historical performance and comparison